Pain in Hidradenitis Suppurativa: A Cross-sectional Study of 1,795 Patients.
acne inversa
numerical rating scale
hidradenitis suppurativa
Journal
Acta dermato-venereologica
ISSN: 1651-2057
Titre abrégé: Acta Derm Venereol
Pays: Sweden
ID NLM: 0370310
Informations de publication
Date de publication:
05 Jan 2021
05 Jan 2021
Historique:
pubmed:
16
12
2020
medline:
24
6
2021
entrez:
15
12
2020
Statut:
epublish
Résumé
Hidradenitis suppurativa is a chronic, inflammatory skin disorder that affects the pilosebaceous unit of the intertriginous body areas. Pain is one of the most important problems in patients with hidradenitis suppurativa. The aim of this study, which included 1,795 patients, was to evaluate the prevalence and characteristics of pain. The intensity of pain was assessed with a numerical rating scale. In addition, pain intensity was correlated with various clinical features. Pain was reported by 83.6% of subjects. The majority of patients (77.6%) experienced mild pain; women and smokers tended to experience more intense pain. Pain intensity was greater in patients with multiple affected skin areas and correlated positively with the number of those affected areas (r = 0.151, p < 0.001). There was no difference in pain intensity between affected locations. The worst pain was observed in the patients with the most severe disease and it would weaken significantly along with the severity of hidradenitis suppurativa (assessed using the Hurley staging system and the International Hidradenitis Suppurativa Severity Score System).
Identifiants
pubmed: 33320274
doi: 10.2340/00015555-3724
pmc: PMC9309859
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
adv00364Subventions
Organisme : Austrian Science Fund FWF
ID : I 4229
Pays : Austria
Références
J Exp Med. 2020 Sep 7;217(9):
pubmed: 32573694
J Am Acad Dermatol. 2007 Apr;56(4):621-3
pubmed: 17097366
Acta Derm Venereol. 2016 May;96(4):554-6
pubmed: 26631388
J Am Acad Dermatol. 1996 Aug;35(2 Pt 1):191-4
pubmed: 8708018
J Eur Acad Dermatol Venereol. 2021 Jan;35(1):e32-e35
pubmed: 32580237
Can J Physiol Pharmacol. 2013 Nov;91(11):867-72
pubmed: 24117253
Acta Derm Venereol. 2018 Aug 29;98(8):757-761
pubmed: 29756157
Br J Dermatol. 2020 Jan;182(1):166-174
pubmed: 30919930
Dermatology. 2020;236(1):37-45
pubmed: 31434072
J Invest Dermatol. 2013 Jan;133(1):97-103
pubmed: 22931916
J Am Acad Dermatol. 2020 May;82(5):1232-1234
pubmed: 31730843
Br J Dermatol. 2001 Apr;144(4):809-13
pubmed: 11298541
J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S47-51
pubmed: 26470616
J Eur Acad Dermatol Venereol. 2015 Apr;29(4):619-44
pubmed: 25640693
Br J Dermatol. 2009 Oct;161(4):831-9
pubmed: 19438453
Dermatology. 2021;237(1):119-124
pubmed: 31466052
J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1784-1790
pubmed: 29761904
Acta Derm Venereol. 2010 May;90(3):264-8
pubmed: 20526543
Life Sci. 2007 May 30;80(24-25):2214-20
pubmed: 17363005
Eur J Pain. 2017 Jan;21(1):82-91
pubmed: 27301642
Acta Derm Venereol. 2011 May;91(3):328-32
pubmed: 21394419
J Am Acad Dermatol. 2010 Apr;62(4):706-8, 708.e1
pubmed: 20227585
J Eur Acad Dermatol Venereol. 2013 Apr;27(4):473-8
pubmed: 22339940
Br J Dermatol. 2016 Apr;174(4):909-11
pubmed: 26521975
J Invest Dermatol. 2019 Jun;139(6):1294-1305
pubmed: 30528824
Acta Derm Venereol. 2018 Feb 7;98(2):191-194
pubmed: 28971209
Dermatology. 2015;231(2):184-90
pubmed: 26139027
Semin Cutan Med Surg. 2017 Jun;36(2):47-54
pubmed: 28538743
Curr Pain Headache Rep. 2017 Nov 1;21(12):49
pubmed: 29094219
Nat Rev Dis Primers. 2020 Mar 12;6(1):18
pubmed: 32165620